NasdaqHealth CareElectromedical & Electrotherapeutic ApparatusALAMEDA, CA

Vivani Medical, Inc. VANI

Ask your AI

Estimated market cap $91.11M90.20M shares, shares as of Nov 12, 2026CIK 1266806

Insider trades, 12 mo

18 buys · 0 sells

$18.66M bought, open market

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

3.7% of shares · 3 added

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

Q3 2026

What changed in Vivani Medical, Inc.'s latest quarterly report, compared with the one before.

Filed Nov 12, 2026 · Quarter ended Sep 30, 2026

Compared with the 10-Q for the quarter ended Jun 30, 2026. Sections compared: risk factors and legal proceedings.

Read the 10-Q on sec.gov ↗Filing index ↗

Latest 10-Q

What changed in Vivani Medical, Inc.'s latest quarterly report, compared with the one before.

Loading…

Insider trades

18 in 12 mo

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Recent insider trades

Donald Dwyer Chief Business Officer	Nov 12 Form 4 ↗	Buy	+$15.5K 15,000 sh @ $1.03	+3.1%
Donald Dwyer Chief Business Officer	Nov 12 Form 4 ↗	Buy	+$4,150 5,000 sh @ $0.83	+3.1%
Gregg Williams Director, 10% owner	Jul 15 Form 4 ↗	Buy	+$1000.0K 793,650 sh @ $1.26	-28.3%
Gregg Williams Director, 10% owner	Jun 15 Form 4 ↗	Buy	+$2.0M 1.59M sh @ $1.26	-10.6%
Gregg Williams Director, 10% owner	May 15 Form 4 ↗	Buy	+$2.0M 1.59M sh @ $1.26	-15.7%

All VANI insider trades →Planned sales (Form 144): see notices

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

3.36M shares

27 funds report VANI. Values checked against market prices.

Funds own 5.8% of shares (Q2 2026)

38 funds hold the stock.

Q3 2026: 3.7% · 5,560 of ~8,900 funds reported so far

Q2 20256.8%
Q3 20255.4%
Q4 20257.6%
Q1 20266.6%
Q2 20265.8%
Q3 2026 (so far)3.7%

Q3 2026. 5 new, 3 added to, 9 trimmed, 15 exited since Q2 2026.

Top 13F holders
#
1	Vanguard Capital Management LLC 13F ↗	1.44M	$1.8M	-18.7%
2	Geode Capital Management, LLC 13F ↗	518,622	$643.2K	-11.8%
3	Commonwealth Equity Services, LLC 13F ↗	320,565	$397.5K	-3.0%
4	BlackRock, Inc. 13F ↗	293,187	$363.6K	-2.9%
5	Vanguard Fiduciary Trust Co 13F ↗	232,318	$288.1K	-28.6%
6	State Street Corp 13F ↗	154,965	$192.2K	unchanged
7	Jane Street Group, LLC 13F ↗	122,343	$151.7K	New
8	Arax Advisory Partners 13F ↗	100,000	$124.0K	New
9	MAI Capital Management 13F ↗	99,870	$123.8K	unchanged
10	Vanguard Global Advisers, LLC 13F ↗	16,279	$20.2K	unchanged

Download CSV Every fund that holds VANI, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What Vivani Medical, Inc. and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What Vivani Medical, Inc. and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report

Funds holding the stock by quarter

Q3 2022	28	—	4.41M	$10.0M
Q4 2022	35	+7	4.53M	$3.9M
Q1 2023	33	-2	4.29M	$4.3M
Q2 2023	33	0	3.68M	$4.4M
Q3 2023	32	-1	3.55M	$3.6M
Q4 2023	31	-1	3.46M	$3.5M
Q1 2024	25	-6	6.14M	$11.4M
Q2 2024	28	+3	5.70M	$7.2M
Q3 2024	28	0	5.74M	$6.7M
Q4 2024	32	+4	4.98M	$5.8M
Q1 2025	29	-3	4.76M	$5.0M
Q2 2025	32	+3	4.05M	$5.2M
Q3 2025	29	-3	3.92M	$5.5M
Q4 2025	35	+6	5.56M	$6.8M
Q1 2026	43	+8	5.61M	$5.6M
Q2 2026	38	-5	5.22M	$6.5M
Q3 2026	27	-11	3.36M	$4.2M

Each point is a quarter-end, from Q3 2022 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (92854B109). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q3 2022) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes1 in 12 mo 8-K events5 in 90 days PatentsNone on record Short interestFINRA · updated Oct 15 Planned insider salesNone in 12 mo Executive pay3 fiscal years Wikipedia attentionNone on record SEC enforcementNone on record Clinical trials1 active IPO history2 registrations Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: Vivani Medical, Inc.
Address: 1350 S. LOOP ROAD, ALAMEDA, CA 94502
Phone: 415-506-8462
Fiscal year ends: Dec 31
Filer category: Non-accelerated filer, smaller reporting company
Incorporated in: DE
Listed as: VANI (Nasdaq)
Former names: SECOND SIGHT MEDICAL PRODUCTS INC (until 2022); SECOUND SIGHT MEDICAL PRODUCTS INC (until 2003)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$1.01+$0.03 (+2.70%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $0.9834 · High $1.18Nov 13, 2026

Aug 13, 2026Low $0.9834 · High $1.49Nov 13, 2026

Nov 13, 2025Low $0.938 · High $1.60Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.